subcutaneous immunotherapy

BIOLOGICAL3 trials

Sponsors

Nagakura Ken-ichi, ALK-Abelló A/S

Conditions

AsthmaAtopic DermatitisConjunctivitisRhinitisSoy milk Pollen-Food Allergy Syndrome Oral allergy syndrome

Phase 2

Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients

CompletedNCT00857779

ALK-Abelló A/SAsthma, Conjunctivitis, Rhinitis

Start: 2009-02-28End: 2009-10-31Updated: 2013-02-08

Birch subcutaneous immunotherapy for children with soybean pollen-food allergy syndrome

RecruitingJPRN-jRCTs031260091

Nagakura Ken-ichiSoy milk Pollen-Food Allergy Syndrome Oral allergy syndrome

Start: 2026-06-01Target: 30Updated: 2026-06-29

Phase 3

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

CompletedNCT00310492

ALK-Abelló A/SAtopic Dermatitis

Start: 2006-04-30End: 2009-11-30Updated: 2015-12-29